STOCK TITAN

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

BiomX Inc. (NYSE American: PHGE), a clinical-stage company focused on natural and engineered phage therapies, has scheduled a conference call and webcast for November 14, 2024, at 8:00 a.m. ET. The event will cover the company's third quarter 2024 financial results, business updates, and program developments. Participants can join via phone at 1-877-407-0724 (U.S) or 1-201-389-0898 (International). The webcast will be accessible through the Investors section of BiomX's website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – PHGE

+4.63%
1 alert
+4.63% News Effect

On the day this news was published, PHGE gained 4.63%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

NESS ZIONA, Israel, Nov. 12, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Thursday, November 14, 2024, at 8:00 a.m. ET, to report third quarter 2024 financial results and provide business and program updates.

To participate in the conference call, please dial 1-877-407-0724 (U.S) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company’s website at www.biomx.com.

About BiomX
BiomX is a clinical-stage company leading the development of natural and engineered phage cocktails and personalized phage treatments designed to target and destroy harmful bacteria for the treatment of chronic diseases with substantial unmet needs. BiomX discovers and validates proprietary bacterial targets and applies its BOLT (“BacteriOphage Lead to Treatment”) platform to customize phage compositions against these targets. For more information, please visit www.biomx.com, the content of which does not form a part of this press release.

BiomX, Inc.
Ben Cohen
benc@biomx.com


FAQ

When will BiomX (PHGE) report Q3 2024 earnings?

BiomX will report its third quarter 2024 financial results on Thursday, November 14, 2024, at 8:00 a.m. ET.

How can I access BiomX's (PHGE) Q3 2024 earnings call?

You can access the call by dialing 1-877-407-0724 (U.S) or 1-201-389-0898 (International), or via webcast through the Investors section of BiomX's website at www.biomx.com.

What will BiomX (PHGE) discuss in their November 14 conference call?

BiomX will discuss their third quarter 2024 financial results, provide business updates, and share program developments during the call.
Biomx Inc

NYSE:PHGE

PHGE Rankings

PHGE Latest News

PHGE Latest SEC Filings

PHGE Stock Data

8.33M
1.22M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
Israel
DOVER